User:Bs20dp/Muramyl dipeptide/Bibliography


 * Ogawa C, Liu YJ, Kobayashi KS. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011 Sep;7(3):180-197. doi: 10.2174/157340711796817913. PMID: 22180736; PMCID: PMC3241611.


 * Naohiro Inohara, Yasunori Ogura, Ana Fontalba, Olga Gutierrez, Fernando Pons, Javier Crespo, Koichi Fukase, Seiichi Inamura, Shoichi Kusumoto, Masahito Hashimoto, Simon J. Foster, Anthony P. Moran, Jose L. Fernandez-Luna, Gabriel Nuñez. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: IMPLICATIONS FOR CROHN′S DISEASE.* Journal of Biological Chemistry, Volume 278, Issue 8, 2003, Pages 5509-5512, ISSN 0021-9258, https://doi.org/10.1074/jbc.C200673200.


 * Watanabe, Tomohiro; Asano, Naoki; Murray, Peter J.; Ozato, Keiko; Tailor, Prafullakumar; Fuss, Ivan J.; Kitani, Atsushi; Strober, Warren (2008-01-10). "Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis". Journal of Clinical Investigation. doi:10.1172/JCI33145. ISSN 0021-9738.


 * Li X, Yu J, Xu S, Wang N, Yang H, Yan Z, Cheng G, Liu G. Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer. Glycoconj J. 2008;25(5):415–25. [PubMed] [Google Scholar ]

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.

Outline of proposed changes
Click on the edit button to draft your outline.